Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

SK Biopharmaceuticals divulges PRMT5 inhibitors

May 17, 2021

Phase Ib/IIa trial evaluates tigilanol tiglate with pembrolizumab in advanced melanoma

May 14, 2021

Enrollment opens in phase I/II study of BLU-945 in patients with EGFR mutant NSCLC

May 14, 2021

H. pylori oncoprotein-induced genome instability may underlie gastric cancer

May 14, 2021

Alphala patents anticancer compounds

May 14, 2021

New METTL3 inhibitors identified at Accent Therapeutics

May 14, 2021

Dosing begins in phase II trial of onapristone and anastrozole in endometrial cancer

May 13, 2021

New Angex Pharmaceutical anticancer compounds show preclinical potential

May 13, 2021

ShanghaiTech University, Fudan University patent new PROTACs

May 13, 2021

Suzhou Raymon Pharmaceuticals discovers PI3K-alpha inhibitors

May 13, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...